Eli Lilly (LLY) and Novo Nordisk (NVO) to dominate as TD Cowen lifts 2030 sales forecast for GLP-1 class of obesity/ diabetes ...
While Wade has the background to fill that role, the team has had mixed results across its strategies since Santoro left. The managers lean heavily on the firm’s central resources for additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results